Cite
HARVARD Citation
Oba, T. et al. (2021). In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models. Journal for immunotherapy of cancer. 9 (5), p. . [Online].